orphenadrine has been researched along with Restless Legs Syndrome in 2 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
Restless Legs Syndrome: A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neustadt, DH | 1 |
| Morgan, LK | 1 |
2 other studies available for orphenadrine and Restless Legs Syndrome
| Article | Year |
|---|---|
Therapy for restless legs syndrome.
Topics: Humans; Muscle Relaxants, Central; Orphenadrine; Restless Legs Syndrome; Sleep Wake Disorders | 1996 |
Letter: Restless legs: precipitated by beta blockers, relieved by orphenadrine.
Topics: Adolescent; Female; Humans; Male; Middle Aged; Orphenadrine; Pindolol; Restless Legs Syndrome | 1975 |